BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 34466010)

  • 1. Reactive Langerhans Cell Proliferation Mimicking Langerhans Cell Histiocytosis in Association with Sézary Syndrome: A Case Report and Literature Review.
    Zhang J; Ma S; Yu J; Zheng S; Miao Y; Wang P; Yan X
    Clin Cosmet Investig Dermatol; 2021; 14():1023-1028. PubMed ID: 34466010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Langerhans cell histiocytosis of an intra-mammary lymph node in an 18-year-old woman.
    Ungari M; Ferrero G; Varotti E; Gusolfino MD; Manotti L; Tanzi G; Trombatore M; Bertoni R
    Pathologica; 2020 Mar; 112(1):50-55. PubMed ID: 32202540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eruptive Junctional Nevi Appearing During Langerhans Cell Histiocytosis Treatment.
    Mendonça-Sanches M; Rolim I; Costa-Rosa J; Caldas G; Moura C
    Eur J Case Rep Intern Med; 2019; 6(6):001088. PubMed ID: 31293989
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Case report: Common clonal origin of concurrent langerhans cell histiocytosis and acute myeloid leukemia.
    Kazama S; Yokoyama K; Ueki T; Kazumoto H; Satomi H; Sumi M; Ito I; Yusa N; Kasajima R; Shimizu E; Yamaguchi R; Imoto S; Miyano S; Tanaka Y; Denda T; Ota Y; Tojo A; Kobayashi H
    Front Oncol; 2022; 12():974307. PubMed ID: 36185232
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Concomitant Langerhans cell histiocytosis of cervical lymph nodes in adult patients with papillary thyroid carcinoma: A report of two cases and review of the literature.
    Maraqa B; Al-Ashhab M; Kamal N; El Khaldi M; Sughayer M
    Autops Case Rep; 2021; 11():e2021253. PubMed ID: 34307217
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Adult Onset of BRAF(V600E)-Mutated Langerhans Cell Histiocytosis with Cutaneous Involvement Successfully Diagnosed by Immunohistochemical Staining.
    Tono H; Fujimura T; Kakizaki A; Furudate S; Ishibashi M; Aiba S
    Case Rep Dermatol; 2015; 7(3):237-40. PubMed ID: 26500535
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Langerhans cell histiocytosis and Erdheim-Chester disease, both with cutaneous presentations, and papillary thyroid carcinoma all harboring the BRAF(V600E) mutation.
    Johnson WT; Patel P; Hernandez A; Grandinetti LM; Huen AC; Marks S; Ho J; Monaco SE; Jaffe R; Picarsic J
    J Cutan Pathol; 2016 Mar; 43(3):270-5. PubMed ID: 26454140
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apparent Lack of
    Kemps PG; Zondag TC; Steenwijk EC; Andriessen Q; Borst J; Vloemans S; Roelen DL; Voortman LM; Verdijk RM; van Noesel CJM; Cleven AHG; Hawkins C; Lang V; de Ru AH; Janssen GMC; Haasnoot GW; Franken KLMC; van Eijk R; Solleveld-Westerink N; van Wezel T; Egeler RM; Beishuizen A; van Laar JAM; Abla O; van den Bos C; van Veelen PA; van Halteren AGS
    Front Immunol; 2019; 10():3045. PubMed ID: 31998317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Langerhans Cell Histiocytosis Associated With Underlying Hematolymphoid Disorders in Adults: Report of 2 Cases and Review of the Literature.
    Kiavash K; Malone JC
    Am J Dermatopathol; 2018 Aug; 40(8):588-593. PubMed ID: 30035752
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Clinicopathologic features and prognosis of T lymphoblastic lymphoma associated with Langerhans cell histiocytosis].
    Li X; Wang Y; Chen R; Abulaiti D; Ma Z; Miao N; Abulajiang G; Zhang W
    Zhonghua Bing Li Xue Za Zhi; 2014 Aug; 43(8):522-7. PubMed ID: 25346121
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Langerhans Cell Hyperplasia Mimicking Langerhans Cell Histiocytosis: A Rare Complication of COVID-19 Vaccination.
    Qureshi A; Al Khabori M; Al Haddabi IH; Qureshi H; Jawa Z
    Int J Surg Pathol; 2023 Nov; ():10668969231206571. PubMed ID: 37946499
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CSF1R Is Required for Differentiation and Migration of Langerhans Cells and Langerhans Cell Histiocytosis.
    Lonardi S; Scutera S; Licini S; Lorenzi L; Cesinaro AM; Gatta LB; Castagnoli C; Bollero D; Sparti R; Tomaselli M; Medicina D; Calzetti F; Cassatella MA; Facchetti F; Musso T; Vermi W
    Cancer Immunol Res; 2020 Jun; 8(6):829-841. PubMed ID: 32238382
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Acute-phase ITIH4 levels distinguish multi-system from single-system Langerhans cell histiocytosis via plasma peptidomics.
    Murakami I; Oh Y; Morimoto A; Sano H; Kanzaki S; Matsushita M; Iwasaki T; Kuwamoto S; Kato M; Nagata K; Hayashi K; Imashuku S; Gogusev J; Jaubert F; Oka T; Yoshino T
    Clin Proteomics; 2015; 12(1):16. PubMed ID: 26097443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circulating cell-free BRAF
    Héritier S; Hélias-Rodzewicz Z; Lapillonne H; Terrones N; Garrigou S; Normand C; Barkaoui MA; Miron J; Plat G; Aladjidi N; Pagnier A; Deville A; Gillibert-Yvert M; Moshous D; Lefèvre-Utile A; Lutun A; Paillard C; Thomas C; Jeziorski E; Nizard P; Taly V; Emile JF; Donadieu J
    Br J Haematol; 2017 Aug; 178(3):457-467. PubMed ID: 28444728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CyclinD1 Is Useful to Differentiate Langerhans Cell Histiocytosis From Reactive Langerhans Cells.
    Chatterjee D; Vishwajeet V; Saikia UN; Radotra B; De D; Bansal D
    Am J Dermatopathol; 2019 Mar; 41(3):188-192. PubMed ID: 30124506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of the V600D mutation in Exon 15 of the BRAF oncogene in congenital, benign langerhans cell histiocytosis.
    Kansal R; Quintanilla-Martinez L; Datta V; Lopategui J; Garshfield G; Nathwani BN
    Genes Chromosomes Cancer; 2013 Jan; 52(1):99-106. PubMed ID: 22996177
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Multisystem histiocytosis of Langerhans cells associated with Lymphomatoid papulosis: An accidental finding? Case report and literature review].
    Maggio A; Climent F; Turégano P; Sirvent JJ
    Rev Esp Patol; 2019; 52(2):130-135. PubMed ID: 30902378
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Diagnostic and prognostic importance of T-cell receptor gene analysis in patients with Sézary syndrome.
    Fraser-Andrews EA; Russell-Jones R; Woolford AJ; Wolstencroft RA; Dean AJ; Whittaker SJ
    Cancer; 2001 Oct; 92(7):1745-52. PubMed ID: 11745245
    [TBL] [Abstract][Full Text] [Related]  

  • 19. BRAF gene mutations in synchronous papillary thyroid carcinoma and Langerhans cell histiocytosis co-existing in the thyroid gland: a case report and literature review.
    A Al Hamad M; Albisher HM; Al Saeed WR; Almumtin AT; Allabbad FM; A Shawarby M
    BMC Cancer; 2019 Feb; 19(1):170. PubMed ID: 30795755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF V600E mutation correlates with suppressive tumor immune microenvironment and reduced disease-free survival in Langerhans cell histiocytosis.
    Zeng K; Wang Z; Ohshima K; Liu Y; Zhang W; Wang L; Fan L; Li M; Li X; Wang Y; Yu Z; Yan Q; Guo S; Wei J; Guo Y
    Oncoimmunology; 2016 Jul; 5(7):e1185582. PubMed ID: 27622040
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.